StockData
Profound Medical Corp. logo

Profound Medical Corp. (PROF) stock

PROFNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$6.91−0.17 (-2.40%)

Close on Nov 18, 2026Market cap $252.44MP/E –Yield –

Profound Medical free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2025 it was -$38.38M.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$38.38M–
FY2021Dec 31, 2021-$22.39M–

More Profound Medical figures

See a number that looks wrong?